1. Describe the potential effects of GLP-1 receptor agonists on sexual desire, including the proposed role of serotonergic pathways and brain reward circuitry.

2. Identify biological, psychological, and social factors that may influence sexual desire in patients receiving GLP-1 receptor agonist therapy, including hormonal changes, body image, mood, and medication side effects.

3. Evaluate how GLP-1 receptor agonists may affect sexual functioning and psychiatric well-being, recognizing the potential for competing effects and individual variability in patient outcomes.

4. Apply a biopsychosocial approach to assessing sexual health and identifying potential adverse effects in patients receiving GLP-1 receptor agonist medications.